Biotech Values

[flatlander_60048]

Definitely being sarcastic. I find it hard to believe what has happened to the storied corporate culture at JnJ. I think Dew posted a link to an article that provided a in depth look at the quality control deterioration at JnJ. Unfortunately, JnJ has been viewed as a widow and orphans stock. Some of those investors may be sorry if the market decides that JnJ is no longer best of breed.

I'm certain they will have no difficulty tracking down the hip implants because they will all be listed on the class action lawsuit. Unfortunately for the recipients of these implants, there is no easy fix. I guess the bright side is the heightened awareness will lead to intervention before too much tissue damage occurs. That doesn't help the recipients that have already developed problems. Dew is right it will be an expensive fix.

FL